Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients With Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study (URIROX-2)

Investigator: Monica Morgan, MD

Study Coordinator: Michelle Prystash

Status: Enrolling

ClinicalTrials.gov Number: NCT03847090

Phone: 713.441.6564

Protocol Number: Pro00021042

Description

Treatment
More to Explore
Live Chat Available